ES2186550B2 - Nuevos derivados de oxazolidinonas como antibacterianos. - Google Patents

Nuevos derivados de oxazolidinonas como antibacterianos.

Info

Publication number
ES2186550B2
ES2186550B2 ES200101559A ES200101559A ES2186550B2 ES 2186550 B2 ES2186550 B2 ES 2186550B2 ES 200101559 A ES200101559 A ES 200101559A ES 200101559 A ES200101559 A ES 200101559A ES 2186550 B2 ES2186550 B2 ES 2186550B2
Authority
ES
Spain
Prior art keywords
antibacterials
oxazolidinones
new derivatives
derivatives
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101559A
Other languages
English (en)
Other versions
ES2186550A1 (es
Inventor
Castillo Juan Carlos Del
Clotet Juan Huguet
Mancini Ma Isabel Mourelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Vita SA
Original Assignee
Laboratorios Vita SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200101559A priority Critical patent/ES2186550B2/es
Application filed by Laboratorios Vita SA filed Critical Laboratorios Vita SA
Priority to CA002450982A priority patent/CA2450982A1/en
Priority to JP2003508941A priority patent/JP2004521147A/ja
Priority to APAP/P/2003/002942A priority patent/AP2003002942A0/en
Priority to KR10-2003-7017038A priority patent/KR20040030712A/ko
Priority to PL02365476A priority patent/PL365476A1/xx
Priority to HU0400370A priority patent/HUP0400370A2/hu
Priority to EP02738497A priority patent/EP1401834A1/en
Priority to MXPA04000185A priority patent/MXPA04000185A/es
Priority to CNA028128524A priority patent/CN1520412A/zh
Priority to US10/469,283 priority patent/US20040147545A1/en
Priority to CZ2004101A priority patent/CZ2004101A3/cs
Priority to PCT/IB2002/002408 priority patent/WO2003002560A1/en
Priority to NZ530206A priority patent/NZ530206A/en
Priority to SK57-2004A priority patent/SK572004A3/sk
Priority to HR20031063A priority patent/HRP20031063A2/xx
Priority to OA1200300345A priority patent/OA12639A/en
Priority to IL15943402A priority patent/IL159434A0/xx
Priority to EA200400086A priority patent/EA200400086A1/ru
Priority to EEP200400004A priority patent/EE200400004A/xx
Priority to BR0210667-1A priority patent/BR0210667A/pt
Priority to PE2002000572A priority patent/PE20030134A1/es
Priority to ARP020102399A priority patent/AR035254A1/es
Publication of ES2186550A1 publication Critical patent/ES2186550A1/es
Application granted granted Critical
Publication of ES2186550B2 publication Critical patent/ES2186550B2/es
Priority to CR7195A priority patent/CR7195A/es
Priority to NO20035791A priority patent/NO20035791L/no
Priority to BG108498A priority patent/BG108498A/xx
Priority to IS7088A priority patent/IS7088A/is
Priority to MA27460A priority patent/MA27046A1/fr
Priority to CO03112619A priority patent/CO5540387A2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Nuevos derivados de oxazolidinonas como antibacterianos. La presente invención proporciona nuevos derivados fluorquinolónicos de oxazolidinonas de fórmula general (I) así como procedimientos para su obtención, las correspondientes composiciones farmacéuticas y su utilización para la fabricación de un medicamento destinado al tratamiento de infecciones microbianas. Estos nuevos compuestos son útiles como antibacterianos.
ES200101559A 2001-06-27 2001-06-27 Nuevos derivados de oxazolidinonas como antibacterianos. Expired - Fee Related ES2186550B2 (es)

Priority Applications (29)

Application Number Priority Date Filing Date Title
ES200101559A ES2186550B2 (es) 2001-06-27 2001-06-27 Nuevos derivados de oxazolidinonas como antibacterianos.
IL15943402A IL159434A0 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
APAP/P/2003/002942A AP2003002942A0 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as bacterial agents
KR10-2003-7017038A KR20040030712A (ko) 2001-06-27 2002-06-24 항균제로서 옥사졸리디논의 신규 유도체
PL02365476A PL365476A1 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
HU0400370A HUP0400370A2 (hu) 2001-06-27 2002-06-24 Antibakteriális hatású oxazolidinonszármazékok, előállításukra szolgáló eljárás, azokat hatóanyagként tartalmazó gyógyászati készítmények, alkalmazásuk és intermedierek
EP02738497A EP1401834A1 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
MXPA04000185A MXPA04000185A (es) 2001-06-27 2002-06-24 Nuevos derivados de oxazolidinonas como agentes antibacterianos.
CNA028128524A CN1520412A (zh) 2001-06-27 2002-06-24 作为抗菌剂的新噁唑烷酮衍生物
US10/469,283 US20040147545A1 (en) 2001-06-27 2002-06-24 Derivatives of oxazolidinones as antibacterial agents
CZ2004101A CZ2004101A3 (cs) 2001-06-27 2002-06-24 Nové deriváty oxazolidinonů jako antimikrobiální agens
PCT/IB2002/002408 WO2003002560A1 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
NZ530206A NZ530206A (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
SK57-2004A SK572004A3 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
CA002450982A CA2450982A1 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
OA1200300345A OA12639A (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterialagents.
EEP200400004A EE200400004A (et) 2001-06-27 2002-06-24 Oksasolidinoonide derivaadid kui antibakteriaalsed ained
JP2003508941A JP2004521147A (ja) 2001-06-27 2002-06-24 抗菌剤としてのオキサゾリジノンの新規な誘導体
EA200400086A EA200400086A1 (ru) 2001-06-27 2002-06-24 Новые производные оксазолидинонов в качестве антибактериальных агентов
BR0210667-1A BR0210667A (pt) 2001-06-27 2002-06-24 Derivados de oxazolidinonas como agentes antibacterianos
HR20031063A HRP20031063A2 (en) 2001-06-27 2002-06-24 New derivatives of oxazolidinones as antibacterial agents
PE2002000572A PE20030134A1 (es) 2001-06-27 2002-06-26 Derivados de oxazolidinonas como antibacterianos
ARP020102399A AR035254A1 (es) 2001-06-27 2002-06-26 Derivados fluorquinolonicos de oxazolidinonas utiles como antibacterianos, procedimiento para su obtencion y su utilizacion para la preparacion de una composicion farmaceutica
CR7195A CR7195A (es) 2001-06-27 2003-12-10 Nuevos derivados de oxazolidinonas como antibacterianos
NO20035791A NO20035791L (no) 2001-06-27 2003-12-22 Nye derivater av oksazolidinoner som antibakterielle midler
BG108498A BG108498A (en) 2001-06-27 2003-12-22 New derivatives of oxazolidinones as antibacterial agents
IS7088A IS7088A (is) 2001-06-27 2003-12-22 Nýjar afleiður oxasólidínóna sem bakteríueyðandi lyf
MA27460A MA27046A1 (fr) 2001-06-27 2003-12-23 Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.
CO03112619A CO5540387A2 (es) 2001-06-27 2003-12-26 Nuevos derivados de oxazolidinonas como antibacterianos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101559A ES2186550B2 (es) 2001-06-27 2001-06-27 Nuevos derivados de oxazolidinonas como antibacterianos.

Publications (2)

Publication Number Publication Date
ES2186550A1 ES2186550A1 (es) 2003-05-01
ES2186550B2 true ES2186550B2 (es) 2003-11-16

Family

ID=8498288

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101559A Expired - Fee Related ES2186550B2 (es) 2001-06-27 2001-06-27 Nuevos derivados de oxazolidinonas como antibacterianos.

Country Status (29)

Country Link
US (1) US20040147545A1 (es)
EP (1) EP1401834A1 (es)
JP (1) JP2004521147A (es)
KR (1) KR20040030712A (es)
CN (1) CN1520412A (es)
AP (1) AP2003002942A0 (es)
AR (1) AR035254A1 (es)
BG (1) BG108498A (es)
BR (1) BR0210667A (es)
CA (1) CA2450982A1 (es)
CO (1) CO5540387A2 (es)
CR (1) CR7195A (es)
CZ (1) CZ2004101A3 (es)
EA (1) EA200400086A1 (es)
EE (1) EE200400004A (es)
ES (1) ES2186550B2 (es)
HR (1) HRP20031063A2 (es)
HU (1) HUP0400370A2 (es)
IL (1) IL159434A0 (es)
IS (1) IS7088A (es)
MA (1) MA27046A1 (es)
MX (1) MXPA04000185A (es)
NO (1) NO20035791L (es)
NZ (1) NZ530206A (es)
OA (1) OA12639A (es)
PE (1) PE20030134A1 (es)
PL (1) PL365476A1 (es)
SK (1) SK572004A3 (es)
WO (1) WO2003002560A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
JP4805139B2 (ja) 2003-04-30 2011-11-02 モルホケム アクツィエンゲゼルシャフト フューア コンビナートリッシュ ヒェミー 炭疽および他の感染を治療するためのオキサゾリジノン‐キノリンハイブリッド抗生物質の使用
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
WO2005051933A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
EP1557416A1 (en) * 2004-01-23 2005-07-27 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
BRPI0417193B8 (pt) 2003-12-18 2021-05-25 Morphochem Ag Fuer Komb Chemie antibióticos híbridos de oxazolidinona-quinolona, seus sais monossódicos, dissódicos ou trissódicos e seus pró-fármacos, composições farmacêuticas, e seu uso
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
CN101883768A (zh) 2007-10-02 2010-11-10 财团法人乙卯研究所 具有7元杂环的噁唑烷酮衍生物
NZ589734A (en) * 2008-05-09 2012-11-30 Actelion Pharmaceuticals Ltd 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
MX371037B (es) 2013-05-28 2020-01-14 Morphochem Aktiengesellschaft Fuer Komb Chemie Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas.
US9993469B2 (en) 2013-05-28 2018-06-12 Morphochem Aktiengesellschaft Für Kombinatorishe Chemie Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
CN107286111B (zh) * 2016-03-30 2020-06-19 广东赛法洛药业有限公司 一种噁唑烷酮化合物的制备方法
CN107286182A (zh) * 2016-04-12 2017-10-24 李靖 新型噁唑烷酮‑氟喹诺酮衍生物及用途
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
GB201708606D0 (en) 2017-05-30 2017-07-12 King S College London Antibiotic resistance breakers
CN111527093B (zh) * 2017-11-29 2023-06-09 巴格沃克斯研究有限公司 抗菌杂环化合物及其合成
CN111087409B (zh) * 2018-10-24 2021-06-08 江阴安博生物医药有限公司 一种喹诺酮类化合物及其制备方法和应用
CN112940038A (zh) * 2019-12-11 2021-06-11 华创合成制药股份有限公司 新型噁唑烷酮类化合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE444566B (sv) * 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
DE69019859T2 (de) * 1989-03-30 1995-10-05 Wakunaga Seiyaku Kk Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
JP3933198B2 (ja) * 1994-10-26 2007-06-20 ファルマシア・アンド・アップジョン・カンパニー フェニルオキサゾリジノン抗菌剤
CA2245179A1 (en) * 1996-01-31 1997-08-07 Ube Industries Limited Remedies or preventives for aids
DK1114819T3 (da) * 1996-04-11 2008-04-14 Pharmacia & Upjohn Co Llc Fremgangsmåde til fremstilling af oxazolidinoner
GB9614236D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
AP2003002942A0 (en) 2003-12-24
AR035254A1 (es) 2004-05-05
IL159434A0 (en) 2004-06-01
CN1520412A (zh) 2004-08-11
WO2003002560A1 (en) 2003-01-09
CZ2004101A3 (cs) 2004-07-14
PL365476A1 (en) 2005-01-10
JP2004521147A (ja) 2004-07-15
HRP20031063A2 (en) 2004-04-30
EP1401834A1 (en) 2004-03-31
OA12639A (en) 2006-06-15
HUP0400370A2 (hu) 2004-08-30
BG108498A (en) 2005-03-31
MA27046A1 (fr) 2004-12-20
CR7195A (es) 2004-03-05
CA2450982A1 (en) 2003-01-09
NO20035791L (no) 2004-02-19
PE20030134A1 (es) 2003-04-04
IS7088A (is) 2003-12-22
KR20040030712A (ko) 2004-04-09
MXPA04000185A (es) 2004-03-18
EA200400086A1 (ru) 2004-06-24
EE200400004A (et) 2004-02-16
BR0210667A (pt) 2004-10-05
SK572004A3 (en) 2004-08-03
CO5540387A2 (es) 2005-07-29
US20040147545A1 (en) 2004-07-29
ES2186550A1 (es) 2003-05-01
NZ530206A (en) 2005-07-29

Similar Documents

Publication Publication Date Title
ES2186550B2 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
ATE433447T1 (de) Pyrimiidinverbindungen
SE0302811D0 (sv) Novel compounds
SE0200920D0 (sv) Novel compounds
SE0202539D0 (sv) Compounds
SE0104140D0 (sv) Novel Compounds
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
CR7743A (es) Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf)
SE0300480D0 (sv) Novel compounds
UY28333A1 (es) Inhibidores de caspasa y sus usos.
BRPI0414694A (pt) pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas
ES2243579T3 (es) Derivados de pirazolopirideno.
SE0302139D0 (sv) Novel compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
CY1109187T1 (el) Νεα μακρολιδια
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
SE0303280D0 (sv) Novel compounds
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
ECSP024377A (es) Derivados de benzo (g) quinolina
SE0303090D0 (sv) Novel compounds

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030501

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2186550B2

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312